Carmell Management
Management criteria checks 1/4
Carmell's CEO is Rajiv Shukla, appointed in Aug 2023, has a tenure of less than a year. total yearly compensation is $1.20M, comprised of 12.1% salary and 87.9% bonuses, including company stock and options. directly owns 15.78% of the company’s shares, worth $8.71M. The average tenure of the management team and the board of directors is 17.3 years and 0.5 years respectively.
Key information
Rajiv Shukla
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 12.1% |
| CEO tenure | less than a year |
| CEO ownership | 15.8% |
| Management average tenure | 17.3yrs |
| Board average tenure | less than a year |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$146k | -US$17m |
Compensation vs Market: Rajiv's total compensation ($USD1.20M) is above average for companies of similar size in the US market ($USD663.07K).
Compensation vs Earnings: Insufficient data to compare Rajiv's compensation with company performance.
CEO
Rajiv Shukla (48 yo)
less than a year
Tenure
US$1,203,629
Compensation
Mr. Rajiv Sarman Shukla has been an Executive Chairman of Carmell Therapeutics Corporation since July 2023 & serves as Chief Executive Officer of Carmell Therapeutics Corporation since August 31, 2023. Mr....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | less than a year | US$1.20m | 15.78% $ 8.7m | |
| Chief Financial Officer | no data | US$476.21k | 0.0072% $ 4.0k | |
| Founder and Chief Scientific Officer | 17.3yrs | no data | no data | |
| Founder | 17.3yrs | no data | no data | |
| Founder | 17.3yrs | no data | no data |
17.3yrs
Average Tenure
Experienced Management: CTCX's management team is seasoned and experienced (17.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | less than a year | US$1.20m | 15.78% $ 8.7m | |
| Independent Director | 7.8yrs | US$25.00k | 0% $ 0 | |
| Director | less than a year | US$180.39k | no data | |
| Independent Director | 13.1yrs | US$25.00k | 0.016% $ 9.0k | |
| Independent Director | 3.3yrs | US$25.00k | 0.28% $ 152.5k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | less than a year | US$167.89k | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | less than a year | US$167.89k | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
0.5yrs
Average Tenure
60yo
Average Age
Experienced Board: CTCX's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.